Clinical Trial Update: Hydroxychloroquine in Giant Cell Arteritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating hydroxychloroquine for Giant Cell Arteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Giant Cell Arteritis | Phase 3 | Status: COMPLETED